ProShare Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Sell
13,864
-2,341
-14% -$71.7K ﹤0.01% 1073
2026
Q1
$540K Sell
16,205
-2,360
-13% -$79.2K ﹤0.01% 1013
2025
Q4
$642K Buy
18,565
+1,713
+10% +$54.6K ﹤0.01% 1005
2025
Q3
$459K Sell
16,852
-3,600
-18% -$87.1K ﹤0.01% 1164
2025
Q2
$430K Sell
20,452
-2,203
-10% -$42.3K ﹤0.01% 1202
2025
Q1
$371K Sell
22,655
-5,227
-19% -$111K ﹤0.01% 1271
2024
Q4
$717K Buy
27,882
+6,752
+32% +$191K ﹤0.01% 1067
2024
Q3
$669K Buy
21,130
+7,210
+52% +$273K ﹤0.01% 965
2024
Q2
$489K Sell
13,920
-3,127
-18% -$124K ﹤0.01% 990
2024
Q1
$748K Buy
17,047
+2,966
+21% +$128K ﹤0.01% 884
2023
Q4
$501K Buy
14,081
+3,265
+30% +$97.5K ﹤0.01% 1034
2023
Q3
$292K Buy
10,816
+47
+0.4% +$1.19K ﹤0.01% 1220
2023
Q2
$253K Buy
+10,769
New +$221K ﹤0.01% 1389
2022
Q2
Sell
-10,125
Closed -$114K 1949
2022
Q1
$114K Sell
10,125
-2,451
-19% -$36.1K ﹤0.01% 2006
2021
Q4
$297K Buy
12,576
+174
+1% +$4.04K ﹤0.01% 1797
2021
Q3
$316K Sell
12,402
-793
-6% -$18.5K ﹤0.01% 1511
2021
Q2
$277K Buy
13,195
+4,455
+51% +$91.5K ﹤0.01% 1947
2021
Q1
$205K Buy
+8,740
New +$169K ﹤0.01% 2027

Other funds holding IDYA

ProShare Advisors's IDYA Position: Q2 2026 in Review

ProShare Advisors reduced its IDEAYA Biosciences (IDYA) stake by 14% in Q2 2026, selling an estimated $71.7K and leaving 13,864 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

ProShare Advisors first reported a position in IDYA in Q1 2021 and has held it in 18 quarters since. The position peaked at $748K in Q1 2024. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • ProShare Advisors held 13,864 shares of IDEAYA Biosciences worth $517K as of Q2 2026.
  • ProShare Advisors sold 2,341 IDEAYA Biosciences shares in Q2 2026, an estimated $71.7K.
  • IDEAYA Biosciences made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1073 holding.
  • ProShare Advisors first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 18 quarters since.
  • ProShare Advisors's IDEAYA Biosciences position peaked at $748K in Q1 2024.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.